Johann S. de Bono, Niven Mehra, Mei Tang, Siruo Wang, Fariba Jafari, Kentaro Imai, Eleni Efstathiou. "IDeate-Prostate02: A phase 1/2, open-label umbrella substudy of ifinatamab deruxtecan-based treatment combinations or as monotherapy in participants with previously treated metastatic castration-resistant prostate cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.tps297